Viewing Study NCT00691028


Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2025-12-26 @ 10:37 AM
Study NCT ID: NCT00691028
Status: COMPLETED
Last Update Posted: 2014-03-04
First Post: 2008-06-03
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid Arthritis
Sponsor: Tanabe Pharma Corporation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-09
Start Date Type: None
Primary Completion Date: 2007-05
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2008-06-03
First Submit QC Date: None
Study First Post Date: 2008-06-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-01-29
Results First Submit QC Date: None
Results First Post Date: 2013-05-20
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-01-30
Last Update Post Date: 2014-03-04
Last Update Post Date Type: ESTIMATED